RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 44.45%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+44.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$166M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1 +$17.2M
2 +$13.3M
3 +$11.4M
4
NUVL icon
Nuvalent
NUVL
+$10.9M
5
VERA icon
Vera Therapeutics
VERA
+$10.3M

Top Sells

1 +$19M
2 +$14.8M
3 +$13.2M
4
CYTK icon
Cytokinetics
CYTK
+$13.1M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$11.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
76
Ocular Therapeutix
OCUL
$2.15B
$3.22M 0.3%
265,000
+63,000
ASND icon
77
Ascendis Pharma
ASND
$14.8B
$3.2M 0.3%
+15,000
JANX icon
78
Janux Therapeutics
JANX
$856M
$3.11M 0.29%
225,377
+125,250
PRVA icon
79
Privia Health
PRVA
$2.78B
$2.96M 0.28%
125,000
-69,189
STVN icon
80
Stevanato
STVN
$4.11B
$2.96M 0.28%
147,025
+96,025
VKTX icon
81
Viking Therapeutics
VKTX
$4.01B
$2.92M 0.27%
83,000
-133,288
CYTK icon
82
Cytokinetics
CYTK
$7.85B
$2.82M 0.26%
44,375
-210,875
A icon
83
Agilent Technologies
A
$32.6B
$2.72M 0.25%
+20,000
XNCR icon
84
Xencor
XNCR
$879M
$2.54M 0.24%
165,750
CNTA
85
Centessa Pharmaceuticals
CNTA
$4.08B
$2.5M 0.23%
+100,000
TGTX icon
86
TG Therapeutics
TGTX
$4.67B
$2.18M 0.2%
73,250
-19,750
BNTX icon
87
BioNTech
BNTX
$21.1B
$1.99M 0.19%
20,870
-15,000
WST icon
88
West Pharmaceutical
WST
$16.8B
$1.93M 0.18%
+7,000
CNC icon
89
Centene
CNC
$17.9B
$1.9M 0.18%
46,231
-123,769
QURE icon
90
uniQure
QURE
$1.14B
$1.9M 0.18%
+79,375
DNLI icon
91
Denali Therapeutics
DNLI
$3.35B
$1.65M 0.15%
100,000
STE icon
92
Steris
STE
$21.8B
$1.52M 0.14%
+6,000
IRTC icon
93
iRhythm Holdings
IRTC
$3.9B
$1.24M 0.12%
7,000
ATEC icon
94
Alphatec Holdings
ATEC
$1.89B
$421K 0.04%
20,000
+2,000
DVAX
95
DELISTED
Dynavax Technologies
DVAX
-772,000
EXAS icon
96
Exact Sciences
EXAS
$19.7B
-348,000
MRUS
97
DELISTED
Merus
MRUS
-53,500
RARE icon
98
Ultragenyx Pharmaceutical
RARE
$2.21B
-119,400
TECH icon
99
Bio-Techne
TECH
$8.26B
-15,000
UHS icon
100
Universal Health Services
UHS
$11.4B
-12,000